Bioinformatic Analysis and Biophysical Characterization Reveal Structural Disorder in G0S2 Protein
Overview
Authors
Affiliations
G0S2 is a small protein of 103 residues in length that is involved in multiple cellular processes. To date, several reports have shown that G0S2 functions by making direct protein-protein interactions with key proteins. In lipolysis, G0S2 specifically interacts with adipose triglyceride lipase, inhibiting its activity and resulting in lipolysis being downregulated. In a similar way, G0S2 also participates in the regulation of apoptosis, cell proliferation, and oxidative phosphorylation; however, information regarding G0S2 structural and biophysical properties is limited. In this work, we conducted a comparative structural analysis of human and mouse G0S2 proteins. Bioinformatics suggests the presence of a disordered C-terminal region in human G0S2. Experimental characterization by size-exclusion chromatography and dynamic light scattering showed that human and mouse G0S2 have different hydrodynamic properties. In comparison to the mouse G0S2, which behaves similar to a globular protein, the human G0S2 shows an elongated conformation, most likely by displaying a disordered C-terminal region. Further analysis of hydrodynamic properties under denaturing conditions suggests the presence of a structural element in the mouse protein that undergoes an order to disorder transition at low urea concentration. Structural analysis by circular dichroism revealed that in native conditions, both proteins are mainly unstructured, showing the presence of beta sheet structures. Further analysis of CD data suggests that both proteins belong to the premolten globule family of intrinsically disordered proteins. We suggest that the intrinsic disorder observed in the G0S2 protein may facilitate its interaction with multiple partners in the regulation of cellular metabolism.
Zarin S, Shariq M, Rastogi N, Ahuja Y, Manjunath P, Alam A Cell Mol Life Sci. 2024; 81(1):203.
PMID: 38698289 PMC: 11065945. DOI: 10.1007/s00018-024-05200-8.
Liang Z, Diao W, Jiang Y, Zhang Y Ann Transl Med. 2023; 10(24):1383.
PMID: 36660674 PMC: 9843419. DOI: 10.21037/atm-22-5618.
Zhang L, Sang X, Han Y, Abulitibu A, Elken M, Mao Z Front Genet. 2022; 13:1004610.
PMID: 36386814 PMC: 9663473. DOI: 10.3389/fgene.2022.1004610.
Zhang S, Zhang J, Cao C, Cai Y, Li Y, Song Y Genes (Basel). 2022; 13(10).
PMID: 36292783 PMC: 9601429. DOI: 10.3390/genes13101898.
Classification of Lung Adenocarcinoma Based on Immune Checkpoint and Screening of Related Genes.
Zhou T, Yang P, Tang S, Zhu Z, Li X, Yang Z J Oncol. 2021; 2021:5512325.
PMID: 34367284 PMC: 8337117. DOI: 10.1155/2021/5512325.